The demand for platelet transfusions is steadily increasing. Platelet concentrates can be obtained either as pooled concentrates from four to six whole-blood donations or as apheresis concentrates ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Seeking to expand their day of transfusion platelet testing capability to include all FDA currently approved platelet types, Verax Biomedical has filed a 510 (k) ...

THE variability in the natural history of both acquired and idiopathic aplastic anemia makes it difficult to evaluate the success of any specific program of therapy. With careful attention to ...

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has cleared the ...

November 16, 2009 — The US Food and Drug Administration (FDA) has approved the first rapid immunoassay (Platelet PGD, Verax Biomedical) for the detection of bacterial contamination in pooled platelets ...

East Hills, New York (Oct. 17, 2005) - - Availability of safe platelets is a fundamental blood transfusion challenge and can be especially problematic in times of emergency. Several studies presented ...

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) announced today that it has entered into an agreement with Haemonetics Corporation (NYSE:HAE) for the sale of Haemonetics’ Acrodose ...

East Hills, NY (October 5, 2005) -- Pall Corporation (NYSE: PLL) announced today FDA clearance to market the new Pall AcrodoseTM PL System. This is the first whole blood derived platelet system for ...

Cerus Corporation announced that the German Red Cross in the Baden-Württemberg - Hessen region (DRK BWH), including Frankfurt, has been granted authorization by the Paul Ehrlich Institute (PEI) to ...

A blood centrifuge rotates between 3,000 and 5,000 times per minute, causing blood to separate into three distinct layers: dark and dense red blood cells at the bottom, a very thin layer of white ...